Crossmark

<scp>MLLT</scp> 6 maintains <i> <scp>PD</scp> ‐L1 </i> expression and mediates tumor immune resistance

Crossref DOI link: https://doi.org/10.15252/embr.202050155

Published Online: 2020-10-15

Published Print: 2020-12-03

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Sreevalsan, Sandeep

Döring, Marietta

Paszkowski‐Rogacz, Maciej https://orcid.org/0000-0002-8245-6006
Brux, Melanie

Blanck, Carolina

Meyer, Marten

Momburg, Frank

Buchholz, Frank https://orcid.org/0000-0002-4577-3344
Theis, Mirko https://orcid.org/0000-0003-3840-6156
Funding

Funding for this research was provided by:

Technische Universität Dresden

German Cancer Research Center
License Information

Version of Record valid from 2020-10-15
More Information

Publication History

Received: 2020-02-05

Accepted: 2020-09-22

Published: 2020-10-15